We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Long Non-Coding RNA Identified Modulates Synaptic Morphology and Function

By LabMedica International staff writers
Posted on 24 Oct 2018
Print article
Image: Golgi-stained neurons in human hippocampal tissue (Photo courtesy of Wikimedia Commons).
Image: Golgi-stained neurons in human hippocampal tissue (Photo courtesy of Wikimedia Commons).
A specific long non-coding RNA that exists in the hippocampal neurons of the brain was found to be enriched in the cells' nuclei and was shown to be necessary for modulating synaptic communication, synapse density, synapse morphology, and dendritic tree complexity.

Long non-coding RNAs (lncRNAs) are considered to be non-protein coding transcripts longer than 200 nucleotides. This somewhat arbitrary limit distinguishes lncRNAs from small regulatory RNAs such as microRNAs (miRNAs), short interfering RNAs (siRNAs), Piwi-interacting RNAs (piRNAs), small nucleolar RNAs (snoRNAs), and other short RNAs. LncRNAs have been found to be involved in numerous biological roles including imprinting, epigenetic gene regulation, cell cycle and apoptosis, and metastasis and prognosis in solid tumors. Most lncRNAs are expressed only in a few cells rather than whole tissues, or they are expressed at very low levels, making them difficult to study. Their name notwithstanding, long non-coding RNAs (lncRNAs) have been found to actually encode synthesis of small polypeptides that can fine-tune the activity of critical cellular components.

Despite the growing evidence suggesting that lncRNAs are critical regulators of several biological processes, their functions in the nervous system remain elusive. However, a recent study carried out by investigators at the Scripps Research Institute (Jupiter, FL, USA) begins to clarify the function of these molecules.

The investigators reported in the October 8, 2018, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America that the lncRNA GM12371 played a major role in regulating synaptic transmission, synapse density, and dendritic branching in primary hippocampal neurons. GM12371 expression was regulated by cAMP signaling and was critical for the activity regulated synaptic transmission. Importantly, GM12371 was associated with transcriptionally active chromatin and regulated expression of several genes involved in neuronal growth and development.

"Long noncoding RNAs are often described as "the dark matter of the genome". So, systematic interrogation of their function will illuminate molecular mechanisms of brain development, storage of long-term memories, and degradation of memory during aging and dementia," said senior author Dr. Sathyanarayanan Puthanveettil, associate professor of neuroscience at the Scripps Research Institute. "Both coding and noncoding RNAs are increasingly viewed as druggable targets. Identifying their specific roles in the fundamental biology of functioning of neural circuits might eventually open new ways of treating neuropsychiatric disorders, such as autism and Alzheimer's disease."

Related Links:
Scripps Research Institute

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Ultrasonic Cleaner
UC 300 Series
New
Alpha-Fetoprotein Reagent
AFP Reagent Kit

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.